Gall H - Search Results

1

Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine.

Bloemena E, Gall H, Ransom JH, Pomato N, Murray JH, Bos E, Scheper RJ, Meijer CJ, Hanna MG Jr, Vermorken JB. Bloemena E, et al. Among authors: gall h. Cancer Res. 1993 Feb 1;53(3):456-9. Cancer Res. 1993. PMID: 7678773

2

A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma.

Baars A, Claessen AM, Wagstaff J, Giaccone G, Scheper RJ, Meijer S, Schakel MJ, Gall HE, Meijer CJ, Vermorken JB, Pinedo HM, van den Eertwegh AJ. Baars A, et al. Among authors: gall he. Br J Cancer. 2002 Apr 22;86(8):1230-4. doi: 10.1038/sj.bjc.6600254. Br J Cancer. 2002. PMID: 11953877 Free PMC article. Clinical Trial.

3

Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients.

Korst AE, van der Sterre ML, Gall HE, Fichtinger-Schepman AM, Vermorken JB, van der Vijgh WJ. Korst AE, et al. Among authors: gall he. Clin Cancer Res. 1998 Feb;4(2):331-6. Clin Cancer Res. 1998. PMID: 9516919 Clinical Trial.

4

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.

Baars A, Claessen AM, van den Eertwegh AJ, Gall HE, Stam AG, Meijer S, Giaccone G, Meijer CJ, Scheper RJ, Wagstaff J, Vermorken JB, Pinedo HM. Baars A, et al. Among authors: gall he. Ann Oncol. 2000 Aug;11(8):965-70. doi: 10.1023/a:1008363601515. Ann Oncol. 2000. PMID: 11038032 Free article. Clinical Trial.

5

Pharmacokinetics of carboplatin after i.v. administration.

Elferink F, van der Vijgh WJ, Klein I, Vermorken JB, Gall HE, Pinedo HM. Elferink F, et al. Among authors: gall he. Cancer Treat Rep. 1987 Dec;71(12):1231-7. Cancer Treat Rep. 1987. PMID: 3319135

6

Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.

Korst AE, Gall HE, Vermorken JB, van der Vijgh WJ. Korst AE, et al. Among authors: gall he. Cancer Chemother Pharmacol. 1996;39(1-2):162-6. doi: 10.1007/s002800050553. Cancer Chemother Pharmacol. 1996. PMID: 8995515

7

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG Jr, Pinedo HM. Vermorken JB, et al. Among authors: gall he. Lancet. 1999 Jan 30;353(9150):345-50. doi: 10.1016/S0140-6736(98)07186-4. Lancet. 1999. PMID: 9950438 Clinical Trial.

8

Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.

Welink J, Boven E, Vermorken JB, Gall HE, van der Vijgh WJ. Welink J, et al. Among authors: gall he. Clin Cancer Res. 1999 Sep;5(9):2349-58. Clin Cancer Res. 1999. PMID: 10499604 Clinical Trial.

9

Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study.

Schwartsmann G, van der Vijgh WJ, van Hennik MB, Klein I, Vermorken JB, Dodion P, ten Bokkel Huinink WW, Joggi G, Gall H, Crespeigne N, et al. Schwartsmann G, et al. Among authors: gall h. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1675-81. doi: 10.1016/0277-5379(89)90334-9. Eur J Cancer Clin Oncol. 1989. PMID: 2632251

10

Phase I study of spiroplatin.

Tanis BC, Vermorken JB, ten Bokkel Huinink WW, Klein I, Gall H, van Oosterom AT, Simonetti G, McVie JG, van der Vijgh WJ, Pinedo HM. Tanis BC, et al. Among authors: gall h. Eur J Cancer. 1991;27(3):268-73. doi: 10.1016/0277-5379(91)90513-d. Eur J Cancer. 1991. PMID: 1827311 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters